Mintel last reported on the market for cold and flu remedies and decongestants in December 2006, since which time the market has continued to increase in value, despite a decline in the incidence of cold and flu and a dampening effect on the market from the rising uptake of the flu jab.

Over the last two years, the market has shown strong growth, driven by value-added products, favourable weather conditions and strong demand for decongestants. Major brands such as Lemsip, Beechams and Vicks command high levels of loyalty, but retailers’ own-label products are increasing their presence in the market.

Main report themes

• All-in-one remedies vs specialisation
• Use of decongestants to treat hayfever
• Prevention vs. treatment
• Competition from general analgesics.

Related Reports:
Snapshots US Nasal Products 2009
Snapshots Denmark OTC Pharmaceuticals 2009
Snapshots US OTC Pharmaceuticals 2009
Snapshots Hungary Pharmaceuticals 2009
Snapshots Poland Pharmaceuticals 2009
Snapshots South Africa Pharmaceuticals 2009
Snapshots Spain Pharmaceuticals 2009
Snapshots US Pharmaceuticals 2009
Snapshots Venezuela Pharmaceuticals 2009
Analgesics in Denmark